Study shows people with more Bacteroidales bacteria may have up to 15% more risk of diseaseBacteria in the gut might influence the chance of developing bowel cancer, research suggests, in the latest study to link human health to the microbes within.The gutmicrobiome– the collection of fungi, bacteria and viruses within our gut – is a booming topic of research, with scientists suggesting certain microbial makeups could be linked to conditions ranging from anxiety to obesity.Continue reading... (Source:...
01:01
Discussion Children can be non-verbal for many reasons with most just not wanting to talk in a given situation for a short period of time (e.g. angry with a person, scared to give a speech at school, etc.). Children may have the ability to communicate verbally but for some reason it is physically impaired for a period of time. Selective mutism (SM) “… is characterized by an individual’s consistent failure to speak in social situations in which there is an expectation to speak (e.g., at school),...
01:13
President Trump formally announced his intention to nominate Dr. Stephen M. Hahn, a top executive at The University of Texas M.D. Anderson Cancer Center, to be the next commissioner of the U.S. FDA. (Source: PharmaManufacturing.com)
Sun Nov 03, 2019 19:47
(Natural News) According to transgender dogma, using hormone therapy to try to switch genders is a completely safe, harmless and necessary line of treatment. But recently published research once again confirms that political agendas have no business in a medical setting. According to the latest research, trans women who undergo hormone therapy as part of... (Source: NaturalNews.com)
Sun Nov 03, 2019 12:19
Well, October was a month of change. And not just when it comes to clocks and seasons. It started off with the country due to leave the EU on Hallowe’en – “do or die”, deal or no deal. It ended with another Brexit extension and everyone gearing up for the third general election in four years. But some things are perennial and they’re always on UNISON’s agenda. The union’s month kicked off with our retired members and police and justice staff conferences in Southport. The service group conference...
Thu Oct 31, 2019 15:38
Study by Nottingham researchers shows immune response to tumour cells can reveal diseaseBreast cancer could be detected five years before clinical signs appear in patients thanks to a blood test that could identify the body ’s immune responses to tumour cells. That is the claim that has been made about research to be presented at a national cancer conference in Glasgow on Sunday. However, other cancer experts have warned these claims should be treated with caution.The study is the work of researchers...
Sun Nov 03, 2019 10:13
A supply ship rocketed toward the International Space Station on Saturday with sports car parts, an oven for baking cookies and a vest to protect against radiation. Northrop Grumman launched its Cygnus capsule for NASA from Wallops Island, Virginia. The 8,200-pound shipment (3,700 kilograms) should reach the orbiting lab Monday. “Good launch all the way around,” a ground controller observed. The space station’s astronauts will test the oven by baking chocolate chip cookies from scratch and try...
Sat Nov 02, 2019 17:20
Publication date: Available online 2 November 2019Source: Journal of Photochemistry and Photobiology B: BiologyAuthor(s): Debjani Baruah, Raj Narayan Singh Yadav, Archana Yadav, Archana Moni DasAbstractIn the present systematic study, silver nanoparticles have been synthesized using the fruits of Alpinia nigra. Apart from the presence of saponins, glycosides, alkaloids, steroids, the extract of A. nigra fruits are rich in polyphenols. The Total Flavonoid and Phenol Content of A. nigra fruits extract...
Sun Nov 03, 2019 15:41
ConclusionMigration cannot be experienced independently of a stutter, as both are intrinsically linked to self-identity. The combined stress of migration with stuttering amplified the perception of feeling abnormal and resulted in difficulties with establishing a stable self-identity and a sense of belonging in the new context. Participants found strength in the company of others and considered Australia to be accepting of stuttering. (Source: Journal of Fluency Disorders)
Sun Nov 03, 2019 15:41
Publication date: February 2020Source: Journal of Neurolinguistics, Volume 53Author(s): Lia Călinescu, Anna Giskes, Mila Vulchanova, Giosuè BaggioAbstractHow do comprehenders track dependencies between the plausibility of embedded clauses and of the sentences in which they occur? We investigated processing of Norwegian propositional attitude sentences with plausible or implausible complement clauses (‘Magnus {knows/believes/dreams/doubts/imagines} that mosquitos live off {blood/vodka}’). Using ERPs,...
Sun Nov 03, 2019 15:41
Authors: Sander RW, Osborne CA Abstract Childhood-onset fluency disorder, the most common form of stuttering, is a neurologic disability resulting from an underlying brain abnormality that causes disfluent speech. Stuttering can lead to significant secondary effects, including negative self-perception and negative perception by others, anxiety, and occasionally depression. Childhood-onset fluency disorder affects 5% to 10% of preschoolers. Early identification of stuttering is important...
Fri Nov 01, 2019 00:00
I am trying to find an answer to rules concerning direct supervision. There is an Astro 2018 white paper stating that there is an exemption to direct supervision for CAH ( critical access hospital‘s) and rural hospitals less than 100 beds. There is a clear definition for a critical access hospital by CMS (and a searchable list of hospitals meeting this designation). There does not appear to be a distinct list for classification as a “rural hospital.” How can someone find out if a......
Sun Nov 03, 2019 14:41
PGY2 at a "top 10" program here, and if I had to do it all over again, I wouldn't apply to rad onc or even consider it. It's ridiculous how little our leadership cares about the state of the field. This change in CMS supervision will not affect expansion. In fact, I still expect programs to open because at the end of the day no one cares about what happens in 5-10 years. It's all about how much they can abuse the system now and leave unscathed. Last year, we had fewer apps, more... Perspective...
Sun Nov 03, 2019 00:14
Conditions: Hypercholesterolemia; Breast Cancer; Obesity Interventions: Dietary Supplement: Cholesterol Reducing Strawberry Yogurt Drink (Tesco Ltd); Dietary Supplement: Low Fat Strawberry Yogurt Drinks (Morrisons Ltd) Sponsors: University of Leeds; The Leeds Teaching Hospitals NHS Trust; University of Oslo Not yet recruiting (Source: ClinicalTrials.gov)
Fri Nov 01, 2019 17:00
Condition: Carcinoma, Non-Small-Cell Lung Intervention: Diagnostic Test: ctDNA blood sample Sponsors: The Netherlands Cancer Institute; Roche Pharma AG Recruiting (Source: ClinicalTrials.gov)
Fri Nov 01, 2019 17:00
Condition: Cancer-related Fatigue Interventions: Drug: Fufang E'Jiao Jiang; Drug: placebo containing low-dose fufang E'Jiao Jiang Sponsors: Xiyuan Hospital of China Academy of Chinese Medical Sciences; The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine; Shandong University of Traditional Chinese Medicine Active, not recruiting (Source: ClinicalTrials.gov)
Fri Nov 01, 2019 17:00
Condition: Breast Cancer Female Intervention: Other: Whole Breast Irradiation Sponsor: National Cancer Institute, Egypt Active, not recruiting (Source: ClinicalTrials.gov)
Fri Nov 01, 2019 17:00
Condition: Prostate Cancer Interventions: Radiation: IGRT 45 Gy in 5 fractions of 9 Gy; Radiation: IGRT 24 Gy single dose; Drug: Dexamethasone; Drug: Tamsulosin Sponsor: Albert Einstein College of Medicine Recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
Fri Nov 01, 2019 17:00
Conditions: Colon Cancer; Rectal Cancer; Gastric Cancer Interventions: Other: Group Abdominal Nerve Block with local anesthetics; Other: Group Abdominal Nerve Block with saline Sponsor: Yi Liu Not yet recruiting (Source: ClinicalTrials.gov)
Fri Nov 01, 2019 17:00
Condition: Inflammatory Response Interventions: Drug: dexmedetomidine infusion; Drug: lidocaine infusion; Drug: Placebos Sponsor: National Cancer Institute, Egypt Recruiting (Source: ClinicalTrials.gov)
Fri Nov 01, 2019 17:00
Conditions: Bladder Cancer; LUTS; Pain Intervention: Dietary Supplement: Protoves M1® Sponsor: Cardarelli Hospital Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
Fri Nov 01, 2019 17:00
Conditions: Colorectal Cancer; Colorectal Neoplasms; Colorectal Carcinoma; Colorectal Adenocarcinoma; Colorectal Cancer Metastatic; Colorectal Sarcoma Intervention: Other: No intervention Sponsor: ProgenaBiome Not yet recruiting (Source: ClinicalTrials.gov)
Fri Nov 01, 2019 17:00
Condition: Cancers With HER2 Expression Interventions: Drug: BAY2701439; Drug: BAY2701438 Sponsor: Bayer Not yet recruiting (Source: ClinicalTrials.gov)
Fri Nov 01, 2019 17:00
Conditions: Vulva Cancer; Sentinel Lymph Node Intervention: Procedure: Sentinel node biopsy Sponsors: Diana Zach; Sahlgrenska University Hospital, Sweden; University Hospital, Linkoeping; Skane University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Fri Nov 01, 2019 17:00
Conditions: Breast Cancer; Colon Cancer; Esophageal Cancer; Gastric Cancer; Head and Neck Cancer; Lung Cancer; Ovarian Cancer; Pancreatic Cancer; Renal Cancer; Uterus Cancer Intervention: Drug: 68GA-PSMA, 68GA-FAPi Sponsors: Jonsson Comprehensive Cancer Center; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Fri Nov 01, 2019 17:00
Condition: NSCLC Stage IIIB~IV Intervention: Drug: Atezolizumab Injection; bevacizumab Injection Sponsor: National Taiwan University Hospital Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
Fri Nov 01, 2019 17:00
Condition: Neoplasms Interventions: Drug: BI 1387446; Drug: BI 754091 Sponsor: Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Fri Nov 01, 2019 17:00
Conditions: B Cell ALL; B-Cell Lymphoma; B-cell Non Hodgkin Lymphoma Intervention: Drug: Anakinra Sponsor: Memorial Sloan Kettering Cancer Center Recruiting (Source: ClinicalTrials.gov)
Fri Nov 01, 2019 17:00
Conditions: Gastric Cancer; Hepatocellular Carcinoma; Non-Small-Cell Lung Cancer; Colon Rectal Cancer Intervention: Biological: DC vaccine subcutaneous administration Sponsor: Sichuan University Recruiting (Source: ClinicalTrials.gov)
Thu Oct 31, 2019 17:00
Condition: Head and Neck Cancer Interventions: Behavioral: Yoga Video; Behavioral: Posture and Strengthening Video; Behavioral: Relaxation Video; Behavioral: Breath Work Video; Behavioral: Satisfaction Survey; Behavioral: Guided Yoga Session; Behavioral: Written Yoga Instructions Sponsors: Vanderbilt-Ingram Cancer Center; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Thu Oct 31, 2019 17:00
Conditions: Non-Small Cell Lung Cancer; ALK Gene Rearrangement Positive Intervention: Drug: Ensartinib Sponsor: Xcovery Holding Company, LLC Available (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
Thu Oct 31, 2019 17:00
Condition: Head and Neck Squamous Cell Carcinoma Interventions: Drug: SCT-I10A+chemo; Drug: Placebos+chemo Sponsor: Sinocelltech Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Thu Oct 31, 2019 17:00
Condition: Head and Neck Squamous Cell Carcinoma Intervention: Drug: PD-1 Sponsor: Sinocelltech Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Thu Oct 31, 2019 17:00
Conditions: NSCLC; Melanoma; Kidney Cancer; Urothelial Carcinoma; Head and Neck Cancer Intervention: Other: Breathprint analysis and patient-reported outcomes Sponsors: University Health Network, Toronto; University of Amsterdam Not yet recruiting (Source: ClinicalTrials.gov)
Thu Oct 31, 2019 17:00
Condition: Breast Cancer Intervention: Sponsor: Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Thu Oct 31, 2019 17:00
Condition: Triple Negative Breast Cancer Intervention: Sponsor: Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
Thu Oct 31, 2019 17:00
Conditions: Breast Cancer; Pain, Chronic; Pain, Postoperative; Mastectomy; Lymphedema Intervention: Other: Rehabilitation protocol Sponsor: University of Roma La Sapienza Completed (Source: ClinicalTrials.gov)
Thu Oct 31, 2019 17:00
Conditions: Advanced Renal Cell Carcinoma (All Subtypes); Metastatic Renal Cell Carcinoma (All Subtypes) Intervention: Other: Documentation Sponsor: IKF Klinische Krebsforschung GmbH at Krankenhaus Nordwest Recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
Thu Oct 31, 2019 17:00
Study of Sintilimab, a PD-1 Inhibitor, as Second-line Treatment in FH-deficient Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma; FH-deficient; Sintilimab Intervention: Drug: Sintilimab Sponsor: West China Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Thu Oct 31, 2019 17:00
Condition: Colorectal Cancer Intervention: Diagnostic Test: Faecal immunochemical test Sponsor: University Hospitals Coventry and Warwickshire NHS Trust Recruiting (Source: ClinicalTrials.gov)
Thu Oct 31, 2019 17:00
Condition: Carcinoma, Pancreatic Ductal Interventions: Combination Product: SonoVue; Drug: Chemotherapy Sponsors: St. Olavs Hospital; Norwegian University of Science and Technology Not yet recruiting (Source: ClinicalTrials.gov)
Thu Oct 31, 2019 17:00
Conditions: Pancreatic Cancer; Pancreatic Neoplasms; Pancreatic Ductal Adenocarcinoma; Advanced Cancer Interventions: Drug: Cyclophosphamide; Drug: Fludarabine; Biological: Mutant KRAS G12V-specific TCR tranduced autologous T cells; Drug: Anti-PD-1 monoclonal antibody Sponsors: Guo ShiWei; Providence Cancer Center, Earle A. Chiles Research Institute Not yet recruiting (Source: ClinicalTrials.gov)
Thu Oct 31, 2019 17:00
Conditions: Prostate Cancer; Prostate Adenocarcinoma Intervention: Sponsors: I.M. Sechenov First Moscow State Medical University; Moscow Regional Research and Clinical Institute Moniki n.a. M.F. Vladimirskiy; Pirogov Russian National Research Medical University Recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
Thu Oct 31, 2019 17:00
Condition: Breast Cancer Female Intervention: Sponsor: Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Thu Oct 31, 2019 17:00
Condition: Breast Cancer Intervention: Sponsor: Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Thu Oct 31, 2019 17:00
Condition: Genetic Predisposition to Disease Interventions: Genetic: BRIDGES gene panel testing; Genetic: Breast cancer risk polygenic risk score (PRS); Behavioral: Questionnaires Sponsor: Institut Curie Recruiting (Source: ClinicalTrials.gov)
Thu Oct 31, 2019 17:00
Condition: Frailty Intervention: Sponsor: Rigshospitalet, Denmark Recruiting (Source: ClinicalTrials.gov)
Thu Oct 31, 2019 17:00
Conditions: Acute Myeloid Leukemia; Chronic Myelomonocytic Leukemia; Myeloblasts 10 Percent or More of Bone Marrow Nucleated Cells; Myelodysplastic Syndrome; Myeloproliferative Neoplasm; Recurrent Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia; Secondary Acute M yeloid Leukemia Interventions: Drug: Azacitidine; Drug: Decitabine; Drug: Salsalate; Drug: Venetoclax Sponsors: Rutgers, The State University of New Jersey; National Cancer Institute (NCI) Not yet recruiting...
Thu Oct 31, 2019 17:00
Condition: Lung Cancer Interventions: Drug: Erlotinib HCl 150 mg; Drug: Tarceva® Sponsor: Quadras Scientific Solutions Completed (Source: ClinicalTrials.gov)
Wed Oct 30, 2019 17:00
Conditions: Glioblastoma, IDH-Mutant; Recurrent Glioblastoma Interventions: Biological: Ipilimumab; Biological: Nivolumab Sponsor: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
Wed Oct 30, 2019 17:00
Condition: Non-cutaneous Squamous Cell Carcinoma of Head and Neck Interventions: Drug: ALKS 4230; Drug: Pembrolizumab Sponsors: Alkermes, Inc.; Immune Oncology Network Not yet recruiting (Source: ClinicalTrials.gov)
Wed Oct 30, 2019 17:00
In the emergency department, we see them all the time. The person with a medical problem too serious to ignore, but not quite bad enough to require admission. The patient referred to the specialist who comes back to the ER.“I couldn ’t afford the cash upfront.” The new cancer in the uninsured. The pneumonia without […]Find jobs at Careers by KevinMD.com. Search thousands of physician, PA, NP, and CRNA jobs now. Learn more. (Source: Kevin, M.D. - Medical Weblog)MedWorm Message: Have you tried...
Sun Nov 03, 2019 00:00
Photo credit Cristian Newman Dear Carol: My mom has been undergoing cancer treatment for months and her latest tests show stability which satisfies the oncologist. Unfortunately, this doctor only sees Mom’s cancer and has zero insight into her as a whole person. Mom had early-stage dementia before treatment, but her thought process is now so much worse that we'd like to take her off her cancer medication for a while to see if her mind clears at least somewhat. The family feels that even if this...
Sun Nov 03, 2019 00:00
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου